NCT00004802View on ClinicalTrials.gov

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders

PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 30, 1992

Conditions
Paralysis, Hyperkalemic PeriodicHypokalemic Periodic ParalysisParamyotonia Congenita
Interventions
DRUG

dichlorphenamide

All Listed Sponsors
collaborator

Ohio State University

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004802 - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders | Biotech Hunter | Biotech Hunter